Alpha Omega Wealth Management’s Veracyte VCYT Stock Holding History

Alpha Omega Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-384	Closed	-$11K	–	537
2019 Q2	$11K	Hold	384	–	–	﹤0.01%	433
2019 Q1	$10K	Buy	+384	New	+$7.33K	﹤0.01%	428

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Alpha Omega Wealth Management's VCYT Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 384 shares — an estimated $11K sold.

Alpha Omega Wealth Management first reported a position in VCYT in Q1 2019 and held it in 2 quarters. The position peaked at $11K in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 384 Veracyte shares in Q3 2019, an estimated $11K.
Alpha Omega Wealth Management first reported a position in Veracyte in Q1 2019 and held it in 2 quarters.
Alpha Omega Wealth Management's Veracyte position peaked at $11K in Q2 2019.
187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.